Efficacy and safety of dapagliflozin combined with insulin in overweight or obese individuals with type 2 diabetes

Xiaolong Li; Dianjing Sun; Yan Zhang; Wei Gu; Kunjie Zheng

doi:10.36721/PJPS.2023.36.4.SP.1349-1354.1

original articles

Efficacy and safety of dapagliflozin combined with insulin in overweight or obese individuals with type 2 diabetes

Xiaolong Li, Dianjing Sun, Yan Zhang, Wei Gu, Kunjie Zheng

Vol. 36

Issue 4

Pages 1349-1354

Published 01 Jul 2023

DOI: 10.36721/PJPS.2023.36.4.SP.1349-1354.1

Authors Abstract Related

Authors & Affiliations

Xiaolong Li

Dianjing Sun

Yan Zhang

Wei Gu

Kunjie Zheng

Abstract

To investigate the efficacy and safety of dapagliflozin plus insulin in overweight or obese individuals with type 2 diabetes

Keywords

Type 2 diabetes

dapagliflozin

insulin

overweight

obese

efficacy

safety

Metrics

PlumX Metrics

original articles

Efficacy and safety of dapagliflozin combined with insulin in overweight or obese individuals with type 2 diabetes

Xiaolong Li, Dianjing Sun, Yan Zhang, Wei Gu, Kunjie Zheng

Vol. 36

Issue 4

Pages 1349-1354

Published 01 Jul 2023

DOI: 10.36721/PJPS.2023.36.4.SP.1349-1354.1

Authors Abstract Related

Authors & Affiliations

Xiaolong Li

Dianjing Sun

Yan Zhang

Wei Gu

Kunjie Zheng

Abstract

To investigate the efficacy and safety of dapagliflozin plus insulin in overweight or obese individuals with type 2 diabetes

Keywords

Type 2 diabetes

dapagliflozin

insulin

overweight

obese

efficacy

safety

Metrics

PlumX Metrics

Efficacy and safety of dapagliflozin combined with insulin in overweight or obese individuals with type 2 diabetes

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Efficacy and safety of dapagliflozin combined with insulin in overweight or obese individuals with type 2 diabetes

Authors & Affiliations

Abstract

Keywords

Metrics